Immunotherapy with injectable hydrogels to treat obstructive nephropathy

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 7, 2014, Pages 2173-2180

  Soranno, Danielle E ^a   Lu, Hoang D ^b   Weber, Heather M ^b   Rai, Reena ^b   Burdick, Jason A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

drug delivery; hydrogel; inflammation; kidney; nephropathy

Indexed keywords

CELL DEATH; DRUG DELIVERY; DRUG PRODUCTS; MACROPHAGES; PATHOLOGY;

CHRONIC KIDNEY DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INJECTABLE HYDROGELS; KIDNEY; MACROPHAGE INFILTRATIONS; NEPHROPATHY; UNILATERAL URETERAL OBSTRUCTIONS;

HYDROGELS;

ALBUMIN; INTERLEUKIN 10; PARAFFIN; HYDROGEL;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLUORESCENCE IMAGING; HYDROGEL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CAPSULE; KIDNEY FIBROSIS; MACROPHAGE; MOUSE; MOUSE MODEL; NEPHRITIS; NONHUMAN; TREATMENT OUTCOME; URETER OBSTRUCTION; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; KIDNEY DISEASES; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HYDROGELS; IMMUNOTHERAPY; INTERLEUKIN-10; KIDNEY DISEASES; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 84901485982     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34902     Document Type: Article

References (22)

1. Roth K, Carter W, Chan J,. Obstructive nephropathy in children: Long-term progression after relief of posterior uretheral valve. Pediatrics 2001; 107: 1004-1010.
2. Groothoff J,. Long-term outcomes of children with end-stage renal disease. Pediatr Nephrol 2005; 20: 849-853.
3. Chevalier R, Thornhill B, Forbes M, Kiley SC,. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol 2010; 25: 687-697.
4. Klahr S, Morrissey JJ,. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 2000; 57: S7-S14.
5. Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier RL,. Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 2003; 18: 335-341.
6. Tayal V, Kalra B,. Cytokines and anti-cytokines as therapeutics-An update. Eur J Pharmacol 2008; 579: 1-12.
7. Dhande I, Ali Q, Hussain T,. Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: Role in renoprotection in obese rats. Hypertension. 2013; 61: 1218-1226.
8. Dankers P, van Luyn M, Huizinga-van der Vlag A, van Gemert GML, Petersen AH, Meijer EW, Janssen HM, Bosman AW, Popa ER,. Development and in-vivo characterization of supramolecular hydrogels for intrarenal drug delivery. Biomaterials 2012; 33: 5144-5155.
9. Basu J, Genheimer C, Rivera E, Payne R, Mihalko K, Guthrie K, Bruce AT, Robbins N, McCoy D, Sangha N, Ilagan R, Knight T, Spencer T, Wagner BJ, Jayo MJ, Jain D, Ludlow JW, Halberstadt C,. Functional evaluation of primary renal cell/biomaterial neo-kidney augment prototypes for renal tissue engineering. Cell Trans 2011; 20: 1771-1790.
10. Gao J, Liu R, Wu J, Liu ZQ, Li JJ, Zhou J, Hao T, Wang Y, Du ZY, Duan CM, Wang CY,. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Biomaterials 2012; 33: 3673-3681.
11. Gheisari Y, Yokoo T, Matsumoto K, Fukui A, Sugimoto N, Ohashi T, Kawamura T, Hosoya T, Kobayashi E,. A thermoreversible polymer mediates controlled release of glial cell line-derived neurotrophic factor to enhance kidney regeneration. Artif Organs 2010; 34: 642-647.
12. Ramakumar S, Phull H, Purves T, Funk J, Copeland D, Ulreich JB, Lai LW, Lien YHH,. Novel Delivery of oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy model. J Urol 2005; 174: 133-136.
13. Bernie JE, Ng J, Bargman V, Gardner T, Cheng L, Sundaram CP,. Evaluation of hydrogel tissue sealant in porcine laparoscopic partial-nephrectomy model. J Endourol 2005; 19: 1122-1126.
14. Chevelier R, Forbes M, Thornhill B,. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
15. Lu H, Charati M, Kim I, Burdick JA,. Injectable shear-thinning hydrogels engineered with a self-assembling dock-and-lock mechanism. Biomaterials 2012; 33: 2145-2153.
16. Hubbell J, Thomas S, Swartz M,. Materials engineering for immunomodulation. Nature 2009; 462: 449-460.
17. Lin C, Metters A, Anseth K,. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFα. Biomaterials 2009; 30: 4907-4914.
18. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D,. Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000; 58: 2301-2313.
19. Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK,. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 2005; 288: F406-F411.
20. Imai N, Kaur T, Rosenberg M, Gupta S,. Cellular therapy of kidney diseases. Semin Dial 2009; 22: 629-635.
21. Bussolati B, Hauser P, Carvalhosa R, Camussi G,. Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther 2009; 4: 2-8.
22. Asanuma H, Meldrum D, Meldrum K,. Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 2010; 184: 26-33.